1. Home
  2. PAYC vs BIO Comparison

PAYC vs BIO Comparison

Compare PAYC & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAYC
  • BIO
  • Stock Information
  • Founded
  • PAYC 1998
  • BIO 1952
  • Country
  • PAYC United States
  • BIO United States
  • Employees
  • PAYC N/A
  • BIO N/A
  • Industry
  • PAYC Computer Software: Prepackaged Software
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • PAYC Technology
  • BIO Industrials
  • Exchange
  • PAYC Nasdaq
  • BIO Nasdaq
  • Market Cap
  • PAYC 14.6B
  • BIO 6.0B
  • IPO Year
  • PAYC 2014
  • BIO N/A
  • Fundamental
  • Price
  • PAYC $224.07
  • BIO $257.04
  • Analyst Decision
  • PAYC Hold
  • BIO Strong Buy
  • Analyst Count
  • PAYC 11
  • BIO 4
  • Target Price
  • PAYC $230.00
  • BIO $324.25
  • AVG Volume (30 Days)
  • PAYC 647.3K
  • BIO 374.5K
  • Earning Date
  • PAYC 07-30-2025
  • BIO 07-31-2025
  • Dividend Yield
  • PAYC 0.68%
  • BIO N/A
  • EPS Growth
  • PAYC N/A
  • BIO N/A
  • EPS
  • PAYC 7.02
  • BIO N/A
  • Revenue
  • PAYC $1,913,800,000.00
  • BIO $2,541,100,000.00
  • Revenue This Year
  • PAYC $10.03
  • BIO N/A
  • Revenue Next Year
  • PAYC $9.22
  • BIO $3.49
  • P/E Ratio
  • PAYC $31.35
  • BIO N/A
  • Revenue Growth
  • PAYC 9.87
  • BIO N/A
  • 52 Week Low
  • PAYC $140.69
  • BIO $211.43
  • 52 Week High
  • PAYC $267.76
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • PAYC 35.90
  • BIO 65.41
  • Support Level
  • PAYC $222.20
  • BIO $245.87
  • Resistance Level
  • PAYC $236.24
  • BIO $264.68
  • Average True Range (ATR)
  • PAYC 6.25
  • BIO 7.34
  • MACD
  • PAYC -0.21
  • BIO 1.84
  • Stochastic Oscillator
  • PAYC 19.35
  • BIO 78.94

About PAYC Paycom Software Inc.

Founded in 1998, Paycom is a human capital management software-as-a-service provider addressing customer requirements surrounding payroll, talent acquisition, talent management, HR management, as well as time and labor. The company primarily services midsize businesses within the United States, targeting businesses with 50-10,000 employees. The company primarily generates revenue through the sale of subscriptions providing access to its HCM platform. To a lesser extent, the company also generates revenue from implementation services provided to customers as well as interest income generated from customer funds. As of fiscal 2024, the company serviced slightly over 37,500 customers and stored data on over 7 million employees.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: